Triall Insights. According to Tufts CSDD, the typical Phase III clinical trial conducted during 2016-2021 had an average of 25.
01 May 2023, 12:56
Triall Insights š
According to Tufts CSDD, the typical Phase III clinical trial conducted during 2016-2021 had an average of 25.8 endpoints.
This number is 37% higher compared to 2015, signalling a sharp increase in clinical trial complexity.
Triall is building data-driven solutions that help clinical research professionals design and operate complex clinical trial studies.
Source: csdd.tufts.edu/impact-reports
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help spread the news on Twitter:
#blockchainforhealth #TRL
Same news in other sources
101 May 2023, 12:56
Triall Insights š
According to Tufts CSDD, the typical Phase III clinical trial conducted during 2016-2021 had an average of 25.8 endpoints.
This number is 37% higher compared to 2015, signalling a sharp increase in clinical trial complexity.
Triall is building data-driven solutions that help clinical research professionals design and operate complex clinical trial studies.
Source: csdd.tufts.edu/impact-reports
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help spread the news on Twitter:
#blockchainforhealth #TRL
Triall Insights. According to Tufts CSDD, the typical Phase III clinical trial conducted during 2016-2021 had an average of 25.
Triall Insights š
According to Tufts CSDD, the typical Phase III clinical trial conducted during 2016-2021 had an average of 25.8 endpoints.
This number is 37% higher compared to 2015, signalling a sharp increase in clinical trial complexity.
Triall is building data-driven solutions that help clinical research professionals design and operate complex clinical trial studies.
Source: csdd.tufts.edu/impact-reports
ā”ļø Trade $TRL at bit.ly/tradeTRL
š£ Help spread the news on Twitter:
https://twitter.com/triallofficial/status/1653020244980518914?s=20
#blockchainforhealth #TRL